Auro Pharmacies Inc. DBA Central Drugs

FDA Regulatory Profile

Auro Pharmacies Inc. DBA Central Drugs appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1082-2019, Class III) was initiated on March 22, 2019.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Known Names

auro pharmacies, inc dba central drugs, auro pharmacies inc. dba central drugs

Recent Recalls

NumberClassProductDate
D-1082-2019Class IIIBiotin 10 mg/mL Injection, 30 mL vial, Rx only, 511 S. Harbor Blvd., Building. F, La Habra, CA 90631March 22, 2019